Education

Watch “Understanding the Gene Therapy Process and Aftercare,” from ASGCT and NORD

ASGCT Staff - December 06, 2019

The webinars in this series are designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

The fourth in a series of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available to watch for free.

DOWNLOAD THE SLIDES HERE

This session, held on Nov. 20, covered how patients are identified as candidates for gene therapy, who may be on a gene therapy treatment team, how long the procedure takes, and what to expect during recovery and longer term follow up. Participants heard from ASGCT Members Jerry Mendell, M.D., who has focused his clinical work on neuromuscular diseases for the past five decades; and Barry Byrne, M.D., Ph.D., a pediatric cardiologist who has focused on conditions that lead to skeletal muscle weakness and abnormalities in heart and respiratory function. To learn more about the process of gene therapy, visit our Patient Education portal.

Mark your calendar for the last session in this series, "Life After Gene Therapy," which will be held on Wednesday, December 18. If you missed the first three webinars, you can watch them on this section of our website.

Related Articles

Education

Learn About Gene Therapy for GM1 Gangliosidosis

ASGCT Staff - July 29, 2021
Education

ASGCT, NORD Partner for CME Program

ASGCT Staff - April 19, 2021
Education

Learn How mRNA Vaccines Offer Protection from COVID-19

ASGCT Staff - December 30, 2020
Education

Understanding Ethical Concerns About Germline Gene Editing

ASGCT Staff - December 16, 2020